Abstract
Germany's experience with the concertation procedure has been fairly successful. This paper compares the time frame for approval of applications through the concertation procedure to multi-state procedures and national procedures. Although Germany takes longer than some Member States, it is not nearly as bad as others. The BGA is working hard to decrease approval times.
Get full access to this article
View all access options for this article.
References
1.Council Directive 87/22/EEC and Notice to Applicants Volumes I and II of the Rules Governing Medicinal Products in the EC. .